Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů

Latanoprost a unoprost:

léčba je ordinována v případě, není-li po vyčerpání všech možností antiglaukomatosní terapie léčba dostatečně účinná a operační výkon není indikován.

| 486.9 | S01ED51 | timolol v kombinaci s dorzolamidem | lok. | 1 | ML | 92,38 | P | | 487 | S01F | mydriatika a cykloplegika | lok. | O/OPH | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 487.1 | S01FA04 | cyklopentolát | lok. | 1 | ML | 35,10 | O/OPH | | | | | | | | | | | 487.2 | S01FA06 | tropikamid | lok. | 1 | ML | 8,99 | O/OPH | | 21155 | MYDRUM | gtt oph 10ml 0.5% | ANW | D | | | | | 487.3 | S01FB01 | fenylefrin (koncentrace 10% nebo více) | lok. | 1 | ML | 40,33 | O/OPH | | | | | | | | | | | 487.4 | S01FA01 | atropin (koncentrace do 0,5% včetně) | lok. | 1 | ML | 5,18 | | | 83770 | ATROPIN-POS 0.5% | gtt oph 1x10ml | URS | D | | | | | 487.5 | S01FA01 | atropin (koncentrace nad 0,5%) | lok. | 1 | ML | 5,87 | | | 83771 | ATROPIN-POS 1% | gtt oph 1x10ml | URS | D | | | | | 488 | S01G | dekongestanty a antialergika | lok. | L/OPH,ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 488.1 | S01GA52 | tetryzolin/antihistaminikum | lok. | 1 | ML | 4,06 | L/OPH,ALG | | | | | | | | | | | 488.2 | S01GX | antazolin/tetryzolin | lok. | 1 | ML | 6,06 | L/OPH,ALG | | | | | | | | | | | 488.3 | S01GX01 | kyselina kromoglyková (lékové formy očních kapek) | lok. | 1 | ML | 4,06 | | | | | | | | | | | | 488.4 | S01GX01 | kyselina kromoglyková (lékové formy očních a nosních kapek) | lok. | 1 | ML | 5,43 | L/OPH,ALG,ORL | | 54241 | ALLERGOCROM EYE+NAS.KOMBI-PACK | oph 10ml+nas 15ml | URS | D | | | | | 83651 | CROMOHEXAL COMBI | oph 10ml+nas 15ml | HEX | D | | | | | 488.5 | S01GX02 | levokabastin | lok. | 1 | ML | 17,60 | L/OPH,ALG | | | | | | | | | | | 488.6 | S01GX05 | lodoxamid | lok. | | ML | 14,66 | L/OPH,ALG | | | | | | | | | | | 488.7 | S01GX03 | kyselina spaglumová | lok. | 1 | ML | 14,66 | L/OPH,ALG | | | | | | | | | | | 488.8 | S01GX06 | emedastin | lok. | 1 | ML | 17,60 | L/OPH, ALG | | | | | | | | | | | 488.9 | S01GX07 | azelastin | lok. | 1 | ML | 17,60 | L/OPH, ALG | | 489 | S01HA | lokální místní anestetika | lok. | L/OPH | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 489.1 | S01HA | místní anestetika | lok. | 1 | ML | 11,83 | L/OPH | | | | | | | | | | | 489.2 | S01HA02 | oxybuprokain | lok. | 1 | ML | 11,83 | L/OPH | | 66524 | NOVESIN 0.4% | gtt oph 1x10ml | CBV | CH | | | | | 490 | S01 | jiná oftalmologika | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 490.1 | S01XA | tolazolin (koncentrace 10%) | lok. | 1 | GM | 14,91 | L/OPH | | | | | | | | | | | 490.2 | S01XA20 | umělé slzy a jiné indiferentní přípravky | lok. | 1 | ML | 2,93 | | | 04179 | LACRISYN | gtt oph 1x10ml | GNO | CZ | | | | | 490.3 | S01KA01 | kyselina hyaluronová | lok. | 1 | ML | 1376,58 | Z | | | | | | | | | | | 490.4 | S01XA02 | retinol | lok. | 1 | GM | 2,93 | | | | | | | | | | | | 490.5 | S01XA04 | jodid draselný | lok. | 1 | ML | 4,89 | | | 56118 | JODID DRASELNY 2% UNIMED PHARMA | gtt oph 1x10ml | UPA | SK | | | | | 490.6 | S01XA | jodid draselný a sodný | lok. | 1 | ML | 4,89 | | | 56119 | JODID DRASELNY+SODNY 2% UNIM.PH | gtt oph 1x10ml | UPA | SK | | | | | 490.7 | S01XA | umělé slzy a jiné indiferentní přípravky (v lékové formě gelu) | lok. | 1 | GM | 2,93 | | | | | | | | | | | | 490.8 | S01XA11 | nandrolon | lok. | 1 | ML | 11,20 | | | 491 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | L/ORL | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 491.1 | S02CA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | ML | 27,37 | L/ORL | | | | | | | | | | | 491.2 | S02AA11 | polymyxin B | lok. | 1 | ML | 2,64 | L/ORL | | | | | | | | | | | 491.3 | S02BA | kortikosteroidy a antiinfektiva v kombinaci | lok. | 1 | GM | 22,92 | L/ORL, PDD | | 84575 | OTOBACID N | gtt oto 1x6gm | ASH | D | | | | | 492 | V01AA | extrakty alergenů | p.o. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 492.1 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, úvodní dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.2 | V01AA | extrakty alergenů (nestandardizované, bakteriální, z plísní, udržovací dávka) | p.o. | 1 | BA | 432,70 | L/ALG | | 98393 | H-AL BACT.SEVAC P.O.HAEM.INFL. | sol 10000pnu 1x9ml | SEV | CZ | | | | | 492.3 | V01AA | extrakty alergenů (nestandardizované, úvodní dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.4 | V01AA | extrakty alergenů (nestandardizované, udržovací dávka) | p.o. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 492.5 | V01AA | extrakty alergenů (standardizované, úvodní dávka) | p.o. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 492.6 | V01AA | extrakty alergenů (standardizované, udržovací dávka) | p.o. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 492.7 | V01AA | extrakty alergenů (standardizované, pro sublinguální podání, úvodní dávka) | p.o. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 492.8 | V01AA | extrakty alergenů (stadnardizované, pro sublinguální podání, udržovací dávka) | p.o. | 1 | DF | 692,22 | L/ALG | | 493 | V01AA | extrakty alergenů | intrader. | O/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 493.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | intrader. | 1 | BA | 134,61 | O/ALG | | 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | | | | | 494 | V01AA | extrakty alergenů | PRICK test | O/ALG | | | | | 494.1 | V01AA | extrakty alergenů (diagnostické, jedna lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG | | 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | | | | | 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | | | 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | | | 494.2 | V01AA | extrakty alergenů (diagnostické, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG | | 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | | | 495 | V01AA | extrakty alergenů | parent. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 495.1 | V01AA | extrakty alergenů (nestandardizované, vodné, úvodní dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.2 | V01AA | extrakty alergenů (nestandardizované, vodné, udržovací dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.3 | V01AA | extrakty alergenů (standardizované, vodné, úvodní dávka) | parent. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 495.4 | V01AA | extrakty alergenů (standardizované, vodné, udržovací dávka) | parent. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 495.5 | V01AA | extrakty alergenů (nestandardizované, depotní, úvodní dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.6 | V01AA | extrakty alergenů (nestandardizované, depotní, udržovací dávka) | parent. | 1 | BA | 65% | L/ALG | | | | | | | | | | | 495.7 | V01AA | extrakty alergenů (standardizované, depotní, úvodní dávka) | parent. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 495.8 | V01AA | extrakty alergenů (standardizované, depotní, udržovací dávka) | parent. | 1 | DF | 1168,01 | L/ALG | | 69201 | ALUTARD SQ (TERAP.) 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | | | | | 495.9 | V01AA | extrakty alergenů (standardizované, depotní, z hmyzu, úvodní dávka) | parent. | 1 | DF | 355,64 | L/ALG | | | | | | | | | | | 495.10 | V01AA | extrakty alergenů (standardizované, depotní, z hmyzu, udržovací dávka) | parent. | 1 | DF | 1168,01 | L/ALG | | 57371 | ALUTARD SQ INSECT. 10KU/ML | inj 1x4ml (lahv.3) | EAS | A | | | | | 496 | V03A | všechny jiné terapeutické přípravky | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 496.1 | V03A | antistafylokokový fág. lyzát | lok. | 20 | ML | 289,60 | | | 86170 | STAFAL SEVAC | sus 1x10ml | SEV | CZ | | | | | 497 | V03AB | antidota | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 497.1 | V03AB | deferoxamin | parent. | 1 | GM | 393,57 | K | | 01445 | DESFERAL | inj sic 10x500mg | CGC | CH | | | | | 497.2 | V03AB | trimedoxim + atropin | parent. | | | plně | K | | | | | | | | | | | 497.3 | V03AB | obedoxim | parent. | | | plně | K | | | | | | | | | | | 497.4 | V03AB03 | edetáty | parent. | | | plně | K | | | | | | | | | | | 497.5 | V03AB06 | thiosulfát | parent. | | | plně | K | | | | | | | | | | | 497.6 | V03AB08 | dusitan sodný | parent. | | | plně | K | | | | | | | | | | | 497.7 | V03AB14 | protamin | parent. | 1 | ML | 6,01 | K | | 85787 | PROTAMIN SULFAT 1% GALENIKA | inj 5x5ml/50mg 1% | GLN | YU | | | | | 497.8 | V03AB15 | naloxon | parent. | 0.4 | MG | 11,83 | K | | 88866 | INTRENON | inj 10x1ml/400rg | LEX | CZ | | | | | 94763 | NALOXONE POLFA | inj 10x1 ml/0.4mg | POL | PL | | | | | 497.9 | V03AB16 | ethanol (koncentrace 10%) | parent. | 100 | ML | 20,43 | K | | 69638 | ARDEANUTRISOL GSP | inf 1x500ml | ARD | CZ | | | | | 497.10 | V03AB19 | fysostigmin | parent. | 1 | MG | 10,31 | K | | | | | | | | | | | 497.11 | V03AB24 | digitalisový antitoxin | parent. | 80 | MG | 32726,64 | K | | | | | | | | | | | 497.12 | V03AB25 | flumazenil | parent. | 0.5 | MG | 777,86 | K | | 93214 | ANEXATE | inj 5x5ml/0.5mg | HLR | CH | | | | | 498 | V03AF | antidota užívaná při léčbě cytostatiky | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 498.1 | V03AF03 | kalcium folinát (do 15 mg v jedné tabletě včetně) | p.o. | 60 | MG | 113,99 | | | 96963 | CALCIUMFOLINAT-EBEWE | cps 20x15mg | EBW | A | | | | | 498.2 | V03AF03 | kalcium folinát (nad 15 mg v jedné tabletě) | p.o. | 60 | MG | 117,55 | | | 96964 | CALCIUMFOLINAT-EBEWE | cps 20x100mg | EBW | A | | | | | 498.3 | V03AF01 | mesna | p.o. | 1,2 | GM | 297,04 | B/ONK,HEM | | 87251 | UROMITEXAN TABLETS 400MG | tbl obd 10x400mg | ASD | D | | | | | 499 | V03AF | antidota užívaná při léčbě cytostatiky | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 499.1 | V03AF01 | mesna (do 200 mg v jedné ampuli včetně) | parent. | 0.2 | GM | 29,72 | B/ONK,HEM | | | | | | | | | | | 499.2 | V03AF01 | mesna (nad 200 mg v jedné ampuli) | parent. | 0.4 | GM | 49,42 | B/ONK,HEM | | 75274 | UROMITEXAN 400MG | inj 15x4ml/400mg | ASD | D | | | | | 499.3 | V03AF02 | dexrazoxan | parent. | 0.5 | GM | 4391,10 | B/ONK,HEM | | 96542 | CARDIOXANE | inj sic 1x500mg | CNC | NL | | | | | 499.4 | V03AF03 | kalcium folinát | parent. | 60 | MG | 234,23 | B/ONK,HEM | | 12440 | LEUCOVORIN CA LACHEMA 10 | inj 10x1ml/10mg | LCM | CZ | | | | | 12441 | LEUCOVORIN CA LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | | | 12442 | LEUCOVORIN CA LACHEMA 50 | inj 5x5ml/50mg | LCM | CZ | | | | | 12771 | LEUCOVORIN-TEVA | inj sic 1x50mg | AIC | IL | | | | | 12831 | LEUCOVORIN-TEVA | inj 5x10ml/100mg | AIC | IL | | | | | 12832 | LEUCOVORIN-TEVA | inj 1x5ml/50mg | AIC | IL | | | | | 12833 | LEUCOVORIN-TEVA | inj 1x10ml/100mg | AIC | IL | | | | | 12834 | LEUCOVORIN-TEVA | inj 1x20ml/200mg | AIC | IL | | | | | 12835 | LEUCOVORIN-TEVA | inj 1x30ml/300mg | AIC | IL | | | | | 12836 | LEUCOVORIN-TEVA | inj 1x35ml/350mg | AIC | IL | | | | | 12837 | LEUCOVORIN-TEVA | inj 1x50ml/500mg | AIC | IL | | | | | 75004 | LEUCOVORIN CA LACHEMA 25 | inj sic 1x25mg | LCM | CZ | | | | | 75005 | LEUCOVORIN CA LACHEMA 10 | inj sic 1x10mg | LCM | CZ | | | | | 88636 | LEUCOVORIN CA LACHEMA 10 | inj sic 10x10mg | LCM | CZ | | | | | 91561 | LEUCOVORIN CA LACHEMA 25 | inj sic 10x25mg | LCM | CZ | | | | | 96966 | CALCIUMFOLINAT EBEWE 30MG | inj 5x3ml/30mg | EBW | A | | | | | 96967 | CALCIUMFOLINAT EBEWE 100MG | inj 5x10ml/100mg | EBW | A | | | | | 500 | V03AK | tkáňová lepidla | lok. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 500.1 | V03AK | tkáňová lepidla | lok. | 1 | ML | 3227,24 | X | | 90504 | TISSUCOL KIT | kit 1x2ml | IMM | A | | | | | 90503 | TISSUCOL KIT | kit 1x1ml | IMM | A | | | | | 90502 | TISSUCOL KIT | kit 1x0.5ml | IMM | A | | | | | 90505 | TISSUCOL KIT | kit 1x5ml | IMM | A | | | | | 500.2 | V03AK | tkáňová lepidla | lok. | 1 | C2 | 177,53 | X | | 89822 | TACHOCOMB (2.5X3X0.5CM) | spn 1x1ks | HNP | A | | | | | 74980 | TACHOCOMB (9.5X4.8X0.5CM) | spn 1x1ks | HNP | A | | | | | 501 | V04CD | testy sekrece hormonů hypofýzy | p.o. | K/END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 501.1 | V04CD01 | metyrapon | p.o. | 3 | GM | 421,88 | K/END | | 01359 | METOPIRONE | cps 50x250mg | CGC | CH | | | | | 502 | V04CF | tuberkulinový test | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 502.1 | V04CF01 | tuberkulin | parent. | 0.6 | RG | 277,44 | H | | 68918 | TUBERCULIN PPD RT 23,SSI | inj 10x1.5ml/0.6rg | SST | DK | | | | | 68920 | TUBERCULIN PPD RT 23,SSI | inj 10x5ml/2rg | SST | DK | | | | | 68919 | TUBERCULIN PPD RT 23,SSI | inj 1x5ml/2rg | SST | DK | | | | | 503 | V04CL | testy pro alergické choroby | intrader. | O/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 503.1 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | intrader. | 1 | BA | 134,61 | O/ALG | | 54551 | D-AL POLLENS | inj 1x5ml jsk,jsa | SVF | CZ | | | | | 98502 | D-AL BACTO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98504 | D-AL BACTO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98506 | D-AL DUSTS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98508 | D-AL DUSTS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98510 | D-AL MYCO SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98512 | D-AL MYCO SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98518 | D-AL POLLENS SEVAC | inj 5ml/100pnu | USO | CZ | | | | | 98520 | D-AL POLLENS SEVAC | inj 5ml/1000pnu | USO | CZ | | | | | 98524 | D-AL FOODS SEVAC-KONC.DLE DRUHU | inj po 5ml | USO | CZ | | | | | 503.2 | V04CL | testy pro alergické choroby (diagnostické alergeny, souprava) | intrader. | 1 | BA | 495,05 | O/ALG | | 69220 | ALK WASSERIG SQ(DIAG.)100KU/ML | lyo 1x4.5ml+solv. | EAS | A | | | | | 503.3 | V04CL | testy pro alergické choroby (diagnostické alergeny, 1 lahvička) | PRICK test | 1 | BA | 522,52 | O/ALG | | 53625 | ALYOSTAL PRICK | sol 1x1ml | SLG | F | | | | | 53626 | ALYOSTAL PRICK | sol 1x3ml | SLG | F | | | | | 69225 | SOLUPRICK SQ (DIAG.) | sol 1x3ml | EAS | A | | | | | 84296 | D-AL PRICK TEST POLLENS | sol 1x3ml jsk,jsa | SVF | CZ | | | | | 84300 | D-AL PRICK TEST POLLENS | sol 1x3ml jsk,jsa | SVF | CZ | | | | | 84304 | D-AL PRICK TEST | sol 1x3ml pnu | SVF | CZ | | | | | 503.4 | V04CL | testy pro alergické choroby (diagnostické alergeny, kontrola) | PRICK test | 1 | BA | 363,86 | O/ALG | | 69224 | SOLUPRICK SQ (DIAG.)-KONTROLA | sol 2x3ml | EAS | A | | | | | 504 | V04CX | jiná diagnostika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 504.1 | V04CX | jiná diagnostika (přípravky uvolňující CO2) | p.o. | 1 | DF | 22,88 | | | 46684 | CO2 GRANULAT GUERBET | gra 10x2.938gm | GMG | F | | | | | 505 | V04CX | jiná diagnostika | intrader. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 505.1 | V04CX | jiná diagnostika (diagnostika buněčné imunity) | intrader. | 1 | ML | 127,09 | O | | 45918 | IMUNOSKINTEST | inj 2x1.5+6x1.3ml | SVF | CZ | | | | | 505.2 | V04CX | jiná diagnostika (sulfanum ceruleum) | subkut. | 50 | MG | 251,00 | O | | 90636 | PATENTBLAU V | inj 1x2ml/50mg | BGL | D | | | | | 506 | V04CX | jiná diagnostika | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 506.1 | V04CG03 | histamin | parent. | 10 | MG | 10,07 | O | | | | | | | | | | | 506.2 | V04CG30 | kofein a benzoát sodný | parent. | 0.1 | GM | 5,47 | O | | | | | | | | | | | 506.3 | V04CH01 | inulin | parent. | 5 | GM | 489,33 | O | | | | | | | | | | | 506.4 | V04CJ02 | protirelin | parent. | 0.2 | MG | 215,75 | O | | | | | | | | | | | 506.5 | V04CK01 | sekretin | parent. | 29 | RG | 919,90 | O | | | | | | | | | | | 506.6 | V04CM01 | gonadorelin (do 25 RG v jedné ampuli včetně) | parent. | 0.1 | MG | 225,63 | O | | 506.7 | V04CM01 | gonadorelin (nad 25 RG v jedné ampuli) | parent. | 0.1 | MG | 680,30 | O | | | | | | | | | | | 506.8 | V04CX | jiná diagnostika (fluorescein, 10% koncentrace) | parent. | 1 | ML | 34,56 | O | | | | | | | | | | | 506.9 | V04CX | jiná diagnostika (fluorescein, 25% koncentrace) | parent. | 1 | ML | 126,50 | O | | 90567 | FLUORESCITE | inj 12x2ml 25% | ALC | USA | | | | | 506.10 | V04CE01 | galaktóza | parent. | 1 | DF | 903,92 | O | | | | | | | | | | | 506.11 | V04CX | urea | p.o. | 1 | DF | 1270,85 | Z | | 507 | V06CA | výživa bez fenylalaninu | p.o | L/J4 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 507.1 | V06CA | výživa bez fenylalaninu (suplementovaný bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,33 | L/J4 | | | | | | | | | | | 507.2 | V06CA | výživa bez fenylalaninu (bílkovinný hydrolyzát) | p.o. | 1 | GM | 5,08 | L/J4 | | 88063 | SINFENAL | plv 1x250gm | IMA | SK | | | | | 507.3 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin) | p.o. | 1 | GM | 12,81 | L/J4 | | 93088 | MILUPA PKU 2 | plv po 1x500gm | MLP | D | | | | | 93087 | MILUPA PKU 1 | plv po 1x500gm | MLP | D | | | | | 93089 | MILUPA PKU 3 | plv po 1x500gm | MLP | D | | | | | 507.4 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro děti mladší 18 měsíců) | p.o. | 1 | GM | 25,27 | L/J4 | | 68847 | ANALOG PKU | plv 6x400gm | SGR | GB | | | | | 94414 | ANALOG PKU | plv 1x400gm | SGR | GB | | | | | 507.5 | V06CA | výživa bez fenylalaninu (definované směsi aminokyselin, pro těhotné) | p.o. | 1 | GM | 14,17 | L/J4 | | 508 | V06DA | kombinace sacharidy/proteiny/minerály/vitamíny | p.o. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 508.1 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 80 | GM | 87,40 | H | | | | | | | | | | | 508.2 | V06DA | sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 74,25 | H | | 509 | V06DB | kombinace tuk/sacharidy/proteiny/minerály/vitamíny | p.o. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 509.1 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 100 | GM | 44,87 | H | | 61454 | NUTRISON | plv 1x430gm | NUT | NL | | | | | 509.2 | V06DB | tuk/sacharidy/proteiny/minerály/vitamíny, komb. | p.o. | 500 | ML | 79,38 | H | | 56245 | INKODIET FIBRE | sus por 1x500ml | NDP | D | | | | | 509.3 | V06DC | kombinace sacharidů | p.o. | 100 | GM | 44,87 | H | | 510 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | L/J7 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 510.1 | V06DD | aminokyseliny včetně kombinací s polypeptidy | p.o. | 5 | DF | 90,33 | L/J7 | | 88115 | KETOSTERIL | tbl obd 100 | FRE | D | | | | | 88116 | KETOSTERIL | tbl obd 300 (3x100) | FRE | D | | | | | 88117 | KETOSTERIL | tbl obd 1500=15x100 | FRE | D | | | | | 511 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny | p.o. | L/J11 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 511.1 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka) | p.o. | 100 | GM | 26,88 | | | 72883 | ENFALAC PRAEMATURE FORMULA | plv 1x400gm | BMS | USA | | | | | 511.2 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné bílkoviny kravského mléka s nízkým obsahem laktózy) | p.o. | 100 | GM | 13,83 | L/J11 | | | | | | | | | | | 511.3 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty) | p.o. | 100 | GM | 29,33 | L/J11 | | | | | | | | | | | 511.4 | V06DE | kombinace aminokyseliny/sacharidy/minerály/vitamíny (mléčné proteinové hydrolyzáty s nízkým obsahem laktózy) | p.o. | 100 | GM | 63,54 | L/J11 | | | | | | | | | | | 511.5 | V06 | kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) | p.o. | 100 | GM | 302,25 | P |

Přípravky obsahující kombinace aminokyseliny/sacharidy/minerály/vitamíny (jednotlivé aminokyseliny) jsou ordinovány pacientům s těžkou potravinovou alergií, zvláště na bílkovinu kravského mléka (těžké reakce anafylaktického charakteru, neúspěch terapie extensivně hydrolyzovanými přípravky, potravinová alergie s projevy poškození střevní sliznice), s multiproteinovou alregií, u syndromu krátkého střeva, u malabsorpce při přechodu z parenterální na enterální výživu. Ve výše uvedených případech ordinuje dětem do 3 let věku lékař s atestací II. stupně v oboru pediatrie nebo s atestací I. stupně v oboru pediatrie a zároveň s nástavbovou specializací v oboru gastroenterologie nebo alergologie a klinické imunologie. Po 6 měsících by měl být proveden pokus o reexpozici proteinovým hydrolyzátem.

Vyšetření iotrolanem ordinuje rentgenolog:

• a) pro intrathekální podání,

• b) v ostatních případech po předchozím schválení revizním lékařem.

| 517.1 | V08AB02 | iohexol (koncentrace 180 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 231,11 | K | | 87801 | OMNIPAQUE 180 | inj 10x10ml | NYI | N | | | | | 87802 | OMNIPAQUE 180 | inj 10x15ml | NYI | N | | | | | 517.2 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 199,40 | K | | 04337 | OMNIPAQUE 240 | inj 25x20ml | NYI | N | | | | | 87602 | OMNIPAQUE 240 | inj 6x20ml | NYI | N | | | | | 517.3 | V08AB02 | iohexol (koncentrace 240 mg l/ml, do 15 ml v jedné ampuli včetně) | parent. | 10 | ML | 276,10 | K | | 94219 | OMNIPAQUE 240 | inj 10x10ml | NYI | N | | | | | 517.4 | V08AB02 | iohexol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 04338 | OMNIPAQUE 240 | inj 10x50ml | NYI | N | | | | | 04339 | OMNIPAQUE 240 | inj 6x200ml | NYI | N | | | | | 517.5 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 04328 | OMNIPAQUE 300 | inj 6x20ml | NYI | N | | | | | 04329 | OMNIPAQUE 300 | inj 25x20ml | NYI | N | | | | | 517.6 | V08AB02 | iohexol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K | | 94220 | OMNIPAQUE 300 | inj 10x10ml | NYI | N | | | | | 517.7 | V08AB02 | iohexol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 04330 | OMNIPAQUE 300 | inj 10x50ml (sklo) | NYI | N | | | | | 62466 | OMNIPAQUE 300 | inj 10x50ml (pp) | NYI | N | | | | | 87600 | OMNIPAQUE 300 | inj 10x100ml | NYI | N | | | | | 517.8 | V08AB02 | iohexol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | 04332 | OMNIPAQUE 350 | inj 6x20ml | NYI | N | | | | | 04333 | OMNIPAQUE 350 | inj 25x20ml | NYI | N | | | | | 517.9 | V08AB02 | iohexol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | 87603 | OMNIPAQUE 350 | inj 10x50ml (sklo) | NYI | N | | | | | 62467 | OMNIPAQUE 350 | inj 10x50ml (pp) | NYI | N | | | | | 04335 | OMNIPAQUE 350 | inj 10x100ml | NYI | N | | | | | 517.10 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 236,91 | K | | | | | | | | | | | 517.11 | V08AB03 | kyselina ioxagliková (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K | | | | | | | | | | | 517.12 | V08AB04 | iopamidol (koncentrace 200 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 242,54 | K | | 71989 | IOPAMIRO 200 | inj 5x10ml | BCC | I | | | | | 88657 | IOPAMIRO 200 | inj 1x10ml | BCC | I | | | | | 517.13 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 299,78 | K | | 71993 | IOPAMIRO 300 | inj 5x10ml | BCC | I | | | | | 88654 | IOPAMIRO 300 | inj 1x10ml | BCC | I | | | | | 517.14 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 185,92 | K | | 88655 | IOPAMIRO 300 | inj 1x30ml | BCC | I | | | | | 517.15 | V08AB04 | iopamidol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 169,67 | K | | 71994 | IOPAMIRO 300 | inj 1x100ml | BCC | I | | | | | 88656 | IOPAMIRO 300 | inj 1x50ml | BCC | I | | | | | 517.16 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 365,98 | K | | 88658 | IOPAMIRO 370 | inj 1x10ml | BCC | I | | | | | 517.17 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 15 do 30 ml v jedné ampuli včetně) | parent. | 10 | ML | 224,93 | K | | 88659 | IOPAMIRO 370 | inj 1x30ml | BCC | I | | | | | 517.18 | V08AB04 | iopamidol (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 181,10 | K | | 71988 | IOPAMIRO 370 | inj 1x100ml | BCC | I | | | | | 88660 | IOPAMIRO 370 | inj 1x50ml | BCC | I | | | | | 517.19 | V08AB05 | iopromid (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 77015 | ULTRAVIST-240 | inj 10x50ml | SAG | D | | | | | 517.20 | V08AB05 | iopromid (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 77024 | ULTRAVIST-300 | inj 10x20ml | SAG | D | | | | | 517.21 | V08AB05 | iopromid (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 77017 | ULTRAVIST-300 | inj 10x100ml | SAG | D | | | | | 77016 | ULTRAVIST-300 | inj 10x50ml | SAG | D | | | | | 93628 | ULTRAVIST-300 | inj 1x100ml | SAG | D | | | | | 517.22 | V08AB05 | iopromid (koncentrace 370 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 207,38 | K | | 77019 | ULTRAVIST-370 | inj 10x100ml | SAG | D | | | | | 77018 | ULTRAVIST-370 | inj 10x50ml | SAG | D | | | | | 93625 | ULTRAVIST-370 | inj 1x100ml | SAG | D | | | | | 517.23 | V08AB06 | iotrolan (koncentrace 240 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 429,71 | K/P | | 96349 | ISOVIST 240 | inj 1x10ml 240mg/ml | SAG | D | | | | | 517.24 | V08AB06 | iotrolan (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 534,28 | K/P | | 96351 | ISOVIST 300 | inj 1x10ml 300mg/ml | SAG | D | | | | | 517.25 | V08AB07 | ioversol (koncentrace 160 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 119,48 | K | | 68772 | OPTIRAY 160 | inj 10x50ml | MME | D | | | | | 517.26 | V08AB07 | ioversol (koncentrace 240 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 153,38 | K | | 68922 | OPTIRAY 240 | inj 10x100ml | MME | D | | | | | 98298 | OPTIRAY 240 | inj 10x50ml | MME | D | | | | | 517.27 | V08AB07 | ioversol (koncentrace 300 mg l/ml, do 15 ml v ampuli včetně) | parent. | 10 | ML | 320,96 | K | | 92365 | OPTIRAY 300 | inj 10x10ml | MME | D | | | | | 517.28 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 15 do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | 68923 | OPTIRAY 300 | inj 10x20ml | MME | D | | | | | 517.29 | V08AB07 | ioversol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | 45779 | OPTIRAY 300 | inj 10x125ml(typ c) | MME | D | | | | | 68850 | OPTIRAY 300 | inj 10x50ml | MME | D | | | | | 92366 | OPTIRAY 300 | inj 10x75ml | MME | D | | | | | 92367 | OPTIRAY 300 | inj 10x100ml | MME | D | | | | | 92368 | OPTIRAY 300 | inj 10x150ml | MME | D | | | | | 92369 | OPTIRAY 300 | inj 10x200ml | MME | D | | | | | 517.30 | V08AB07 | ioversol (koncentrace 320 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 186,90 | K | | 68773 | OPTIRAY 320 | inj 10x50ml | MME | D | | | | | 517.31 | V08AB07 | ioversol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | 92370 | OPTIRAY 350 | inj 10x30ml | MME | D | | | | | 517.32 | V08AB07 | ioversol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | 45787 | OPTIRAY 350 | inj 10x125ml(typ c) | MME | D | | | | | 68851 | OPTIRAY 350 | inj 10x50ml | MME | D | | | | | 92371 | OPTIRAY 350 | inj 10x200ml | MME | D | | | | | 517.33 | V08AB10 | iomeprol (koncentrace 150 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 115,90 | K | | | | | | | | | | | 517.34 | V08AB10 | iomeprol (koncentrace 200 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 137,12 | K | | | | | | | | | | | 517.35 | V08AB10 | iomeprol (koncentrace 250 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 157,46 | K | | | | | | | | | | | 517.36 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 231,80 | K | | | | | | | | | | | 517.37 | V08AB10 | iomeprol (koncentrace 300 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 178,32 | K | | | | | | | | | | | 517.38 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 258,97 | K | | | | | | | | | | | 517.39 | V08AB10 | iomeprol (koncentrace 350 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 199,21 | K | | | | | | | | | | | 517.40 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, do 30 ml v ampuli včetně) | parent. | 10 | ML | 285,86 | K | | | | | | | | | | | 517.41 | V08AB10 | iomeprol (koncentrace 400 mg l/ml, nad 50 ml v ampuli) | parent. | 10 | ML | 219,87 | K | | | | | | | | | | | 517.42 | V08AB09 | iodixanol (koncentrace 150 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 215,46 | K | | 45114 | VISIPAQUE 150MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45115 | VISIPAQUE 150MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84339 | VISIPAQUE 150MG l/ML | inj 10x50ml | NYI | N | | | | | 84340 | VISIPAQUE 150MG l/ML | inj 6x200ml | NYI | N | | | | | 517.43 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 336,60 | K | | 84341 | VISIPAQUE 270MG l/ML | inj 10x20ml | NYI | N | | | | | 45118 | VISIPAQUE 270MG l/ML | inj 10x20ml | NRI | IRL | | | | | 517.44 | V08AB09 | iodixanol (koncentrace 270 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 282,14 | K | | 45119 | VISIPAQUE 270MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45120 | VISIPAQUE 270MG l/ML | inj 10x100ml | NRI | IRL | | | | | 45121 | VISIPAQUE 270MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84342 | VISIPAQUE 270MG l/ML | inj 10x50ml | NYI | N | | | | | 84343 | VISIPAQUE 270MG l/ML | inj 10x100ml | NYI | N | | | | | 84344 | VISIPAQUE 270MG l/ML | inj 6x200ml | NYI | N | | | | | 517.45 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, do 30 ml včetně v jedné ampuli) | parent. | 10 | ML | 357,46 | K | | 84345 | VISIPAQUE 320MG l/ML | inj 10x20ml | NYI | N | | | | | 45122 | VISIPAQUE 320MG l/ML | inj 10x20ml | NRI | IRL | | | | | 517.46 | V08AB09 | iodixanol (koncentrace 320 mg l/ml, od 50 ml v jedné ampuli) | parent. | 10 | ML | 287,25 | K | | 45123 | VISIPAQUE 320MG l/ML | inj 10x50ml | NRI | IRL | | | | | 45124 | VISIPAQUE 320MG l/ML | inj 10x100ml | NRI | IRL | | | | | 45125 | VISIPAQUE 320MG l/ML | inj 6x200ml | NRI | IRL | | | | | 84346 | VISIPAQUE 320MG l/ML | inj 10x50ml | NYI | N | | | | | 84347 | VISIPAQUE 320MG l/ML | inj 10x100ml | NYI | N | | | | | 84348 | VISIPAQUE 320MG l/ML | inj 6x200ml | NYI | N | | | | | 518 | V08AC | rozpustné hepatotropní RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 518.1 | V08AC | kyselina iodoxamová (koncentrace 183 mg l/ml) | parent. | 10 | ML | 74,25 | K | | | | | | | | | | | 518.2 | V08AC | kyselina iodoxamová (koncentrace 45 mg l/ml) | parent. | 10 | ML | 37,39 | K | | | | | | | | | | | 518.3 | V08AC04 | adipiodon | parent. | 10 | ML | 39,35 | K | | 519 | V08AD | nerozpustné RTG kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 519.1 | V08AD | iopydol + iopyron | parent. | 10 | ML | 300,70 | K | | | | | | | | | | | 519.2 | V08AD01 | ethylestery jodovaných mastných kyselin | parent. | 10 | ML | 462,54 | K | | 03552 | LIPIODOL ULTRA-FLUID | inj 5x5ml | BGL | D | | | | | 520 | V08BA | RTG kontrastní přípravky obsahující síran barnatý | p.o. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 520.1 | V08BA01 | síran barnatý | p.o. | 100 | GM | 33,29 | K | | 06303 | MICROPAQUE | sus 1x2000ml | GUE | D | | | | | 94370 | PRONTOBARIO 60% | sus 1x5lt | BCC | I | | | | | 520.2 | V08BA01 | síran barnatý (lékové formy pro CT) | p.o. | 7.5 | GM | 154,12 | K | | 44367 | MICROPAQUE CT | sus 1x2000ml/ 100gm | GUE | D | | | | | 46675 | MICROPAQUE CT | sus 1x2000ml/100gm | DEF | F | | | | | 520.3 | V08BA01 | síran barnatý (lékové formy kolon) | p.o. | 100 | GM | 45,75 | K | | 91066 | MICROPAQUE COLON | plv 1x800gm | GUE | D | | | | | 520.4 | V08BA01 | síran barnatý (lékové formy pasty) | p.o. | 100 | GM | 94,58 | K | | 62535 | PRONTOBARIO ESOFAGO | sus 6x250ml (tuba) | BCC | I | | | | | 520.5 | V08BA01 | síran barnatý (lékové formy HD) | p.o. | 100 | GM | 38,08 | K | | 56578 | PRONTOBARIO HD | plv 24x340gm | BCC | I | | | | | 06304 | MICROPAQUE H.D. ORAL | plv 1x416gm | GUE | D | | | | | 521 | V08CA | paramagnetické kontrastní látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 521.1 | V08CA01 | dimeglumin gadopentetat (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | 44487 | MAGNEVIST | inj 5x10ml | SAG | D | | | | | 75659 | MAGNEVIST | inj 1x5ml | SAG | D | | | | | 75660 | MAGNEVIST | inj 1x10ml | SAG | D | | | | | 521.2 | V08CA01 | dimeglumin gadopentetat (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | 96352 | MAGNEVIST | inj 1x20ml | SAG | D | | | | | 521.3 | V08CA03 | gadodiamid (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | 55822 | OMNISCAN 0.5MMOL/ML | inj 10x5ml | NYI | N | | | | | 78815 | OMNISCAN 0.5MMOL/ML | inj 10x10ml | NYI | N | | | | | 521.4 | V08CA03 | gadodiamid (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | 78816 | OMNISCAN 0.5MMOL/ML | inj 10x15ml | NYI | N | | | | | 78817 | OMNISCAN 0.5MMOL/ML | inj 10x20ml | NYI | N. | | | | | 521.5 | V08CA04 | gadoteridol (do 10 ml v 1 ampuli včetně) | parent. | 10 | ML | 1978,62 | K | | | | | | | | | | | 521.6 | V08CA04 | gadoteridol (nad 10 ml v 1 ampuli) | parent. | 10 | ML | 1840,15 | K | | | | | | | | | | | 521.7 | V08CA05 | manganfodipir | parent. | 10 | ML | 1249,06 | K | | 49539 | TESLASCAN | sol 10x50ml | NYI | N | | | | | 521.8 | V08DA01 | mikročástice albuminu s oktafluoropanem | parent. | 1 | DF | 2857,50 | H | | | | | | | | | | | 521.9 | V08DA02 | mikročástice galaktózy | parent. | 1 | GM | 1142,99 | H | | 43916 | LEVOVIST | inj sic 1x4gm+solv. | SAG | D “. | | | |

Čl. II

Tato vyhláška nabývá účinnosti dnem 1. ledna 2001.

Ministr:

prof. MUDr. Fišer, CSc. v. r.